Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea

Yu Seong Hwang,Woo Jin Kim,Tae Hyun Kim,Yukyung Park,Su Mi Jung,Heui Sug Jo
DOI: https://doi.org/10.1186/s12962-024-00526-3
2024-03-04
Cost Effectiveness and Resource Allocation
Abstract:Chronic obstructive pulmonary disease (COPD) is associated with a high readmission rate and poses a significant disease burden. South Korea initiated pilot projects on transitional care services (TCS) to reduce readmissions. However, evidence from cost-effectiveness analyses remains undiscovered. This study aimed to evaluate the cost-effectiveness of TCS in patients with COPD from the healthcare system' perspective.
health policy & services
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate the cost - effectiveness of transitional care services (TCS) for patients with chronic obstructive pulmonary disease (COPD). Specifically, the study aims to evaluate the cost - effectiveness of TCS in reducing the readmission rate of COPD patients from the perspective of the medical system. The research background indicates that COPD is associated with a high readmission rate and brings a significant disease burden to the medical system. Although South Korea has launched pilot projects of TCS to reduce readmission, evidence of cost - effectiveness analysis of these projects is still insufficient. Therefore, this study evaluates the cost - effectiveness of TCS by constructing a Markov model containing six possible medical use states and tests the robustness of the results through sensitivity analysis. The study found that the implementation of TCS can improve the quality - adjusted life years (QALY) of patients of different age groups and save medical expenses. In particular, for patients over 70 years old, TCS shows higher cost - effectiveness. In addition, the study also emphasizes the importance of managing potential comorbidities in TCS interventions. In summary, this paper mainly solves the problem of how to evaluate the cost - effectiveness of TCS for COPD patients from an economic perspective, providing an important reference for policy - makers.